Optimizing polyplexes into synthetic viruses for tumor-targeted gene therapy

Non-viral Gene Therapy: Gene Design and Delivery

Volumn , Issue , 2005, Pages 237-245

  Wagner, Ernst ^a   Kloeckner, Julia ^a   Ogris, Manfred ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547742677     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/4-431-27879-6_19     Document Type: Chapter

References (40)

1. Boeckle S, Von Gersdorff K, Van Der Piepen S, Culmsee C, Wagner E, Ogris M (2004) Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J Gene Med 6:1102-1111
2. Carlisle RC, Etrych T, Briggs SS, Preece JA, Ulbrich K, Seymour LW (2004) Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. J Gene Med 6:337-344
3. Chollet P, Favrot MC, Hurbin A, Coll JL (2002) Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med 4:84-91
4. Dash PR et al. (2000) Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. J Biol Chem. 275:3793-3802
5. De Smedt SC, Demeester J, Hennink WE (2000) Cationic polymer based gene delivery systems. Pharm Res 17:113-26
6. Forrest ML, Koerber JT, Pack DW (2003) A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug Chem 14:934-940
7. Gosselin MA, Guo W, Lee RJ (2001) Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem 12:989-994
8. Han S, Mahato RI, Sung YK, Kim SW (2000) Development of biomaterials for gene therapy. Mol Ther 2:302-317
9. Hildebrandt IJ, Iyer M, Wagner E, Gambhir SS (2003) Optical imaging of transferrin targeted PEI/DNA complexes in living subjects. Gene Ther 10:758-764
10. Kawano T, Okuda T, Aoyagi H, Niidome T (2004) Long circulation of intravenously administered plasmid DNA delivered with dendritic poly (L-lysine) in the blood flow. J Control Release 99:329-337
11. Kircheis R et al. (2002) Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity. Cancer Gene Ther 9:673-680
12. Kircheis R et al. (2001) Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 8:28-40
13. Kramer M et al. (2004) Dendritic polyamines: simple access to new materials with defined treelike structures for application in nonviral gene delivery. Chembiochem 5:1081-1087
14. Kursa M et al. (2003) Novel Shielded Transferrin-Polyethylene Glycol-Polyethylenimine/DNA Complexes for Systemic Tumor-Targeted Gene Transfer. Bioconjug Chem 14:222-231
15. Lim YB, Kim SM, Suh H, Park JS (2002) Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and nontoxic gene delivery carrier. Bioconjug Chem 13:952-957
16. Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189-207
17. Mechtler K, Wagner E (1997) Gene transfer mediated by influenza virus peptides: the role of peptide sequence. New J Chem 21:105-11
18. Merdan T et al. (2003) Pegylated polyethylenimine-fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug Chem 14:989-996
19. Miyata K et al. (2004) Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J Am Chem Soc 126:2355-2361
20. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E (1999) PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 6:595-605
21. Ogris M, Walker G, Blessing T, Kircheis R, Wolschek M, Wagner E (2003) Tumortargeted gene therapy: strategies for the preparation of ligand-polyethylene glycolpolyethylenimine/DNA complexes. J Control Release 91:173-181
22. Okuda T, Sugiyama A, Niidome T, Aoyagi H (2004) Characters of dendritic poly (L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro. Biomaterials 25:537-544
23. Perales JC, Ferkol T, Beegen H, Ratnoff OD, Hanson RW (1994) Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. Proc Natl Acad Sci U S A 91:4086-4090
24. Plank C, Mechtler K, Szoka FJ, Wagner E (1996) Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery. Hum Gene Ther 7:1437-1446
25. Rozema DB, Ekena K, Lewis DL, Loomis AG, Wolff JA (2003) Endosomolysis by Masking of a Membrane-Active Agent (EMMA) for Cytoplasmic Release of Macromolecules. Bioconjug Chem 14:51-57
26. Saito G, Amidon GL, Lee KD (2003) Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Ther 10:72-83
27. Schatzlein AG (2003) Targeting of Synthetic Gene Delivery Systems. J Biomed Biotechnol 2003:149-158
28. Trubetskoy VS, Loomis A, Slattum PM, Hagstrom JE, Budker VG, Wolff JA (1999) Caged DNA does not aggregate in high ionic strength solutions. Bioconjug Chem 10:624-628
29. Uchegbu IF, Dufes C, Elouzi A, Schatzlein AG (2004) Gene therapy with polypropylenimine dendrimers. Proceed 12th Inter Pharm Technol Symp 2004:11-12
30. Verbaan FJ, Oussoren C, Snel CJ, Crommelin DJ, Hennink WE, Storm G (2004) Steric stabilization of poly (2-(dimethylamino) ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice. J Gene Med 6:64-75
31. Verbaan FJ et al. (2001) The fate of poly (2-dimethyl amino ethyl) methacrylate-based polyplexes after intravenous administration. Int J Pharm 214:99-101
32. Wagner E, Kircheis R, Walker GF (2004) Targeted nucleic acid delivery into tumors: new avenues for cancer therapy. Biomed Pharmacother 58:152-161
33. Wagner E, Zenke M, Cotten M, Beug H, Birnstiel ML (1990) Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci U S A 87:3410-3414
34. Walker GF et al. (2005) Toward synthetic viruses: Endosomal pH triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol Ther 11:418-425.
35. Wickham TJ (2003) Ligand-directed targeting of genes to the site of disease. Nat Med 9:135-139
36. Wolschek MF et al. (2002) Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology 36:1106-1114
37. Wu GY, Wu CH (1988) Receptor-mediated gene delivery and expression in vivo. J Biol Chem 262:14621-14624
38. Ziady AG, Ferkol T, Dawson DV, Perlmutter DH, Davis PB (1999) Chain length of the polylysine in receptor-targeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo. J Biol Chem 274:4908-4916
39. Zinselmeyer BH, Mackay SP, Schatzlein AG, Uchegbu IF (2002) The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharm Res 19:960-967
40. Zou SM, Erbacher P, Remy JS, Behr JP (2000) Systemic linear polyethylenimine (L-PEI) - mediated gene delivery in the mouse. J Gene Med 2:128-134